{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:10:04Z","timestamp":1787008204670,"version":"build-2736575974"},"reference-count":119,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Palliative Medicine"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>Pain management in palliative care (PC) is becoming more complex as patients survive longer with life-limiting illnesses and population-wide trends involving opioid misuse become more common in serious illness. Buprenorphine, a generally safe partial mu-opioid receptor agonist, has been shown to be effective for both pain management and opioid use disorder. It is critical that PC clinicians become comfortable with indications for its use, strategies for initiation while understanding risks and benefits. This article, written by a team of PC and addiction-trained specialists, including physicians, nurse practitioners, social workers, and a pharmacist, offers 10 tips to demystify buprenorphine use in serious illness.<\/jats:p>","DOI":"10.1089\/jpm.2022.0399","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T13:25:43Z","timestamp":1662470743000},"page":"120-130","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":26,"title":["Top Ten Tips Palliative Care Clinicians Should Know About Buprenorphine"],"prefix":"10.1177","volume":"26","author":[{"given":"Kyle J.","family":"Neale","sequence":"first","affiliation":[{"name":"The Lois U and Harry R Horvitz Palliative Medicine Program, Department of Palliative Medicine and Supportive Care, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa B.","family":"Weimer","sequence":"additional","affiliation":[{"name":"Program in Addiction Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellar P.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Geisinger Medical Center, Danville, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie Fitzgerald","family":"Jones","sequence":"additional","affiliation":[{"name":"William F. Connell School of Nursing, Boston College, Chestnut Hill, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin G.","family":"Kullgren","sequence":"additional","affiliation":[{"name":"Palliative Medicine Clinical Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin S.","family":"Kale","sequence":"additional","affiliation":[{"name":"Division of Palliative Medicine, Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Childers","sequence":"additional","affiliation":[{"name":"Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6092-3400","authenticated-orcid":false,"given":"Kathleen","family":"Broglio","sequence":"additional","affiliation":[{"name":"Section of Palliative Medicine, Geisel School of Medicine at Dartmouth, Collaboratory for Implementation Sciences at Dartmouth, Lebanon, New Hampshire, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S.","family":"Merlin","sequence":"additional","affiliation":[{"name":"Section of Palliative Care and Medical Ethics and Palliative Research Center, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Peck","sequence":"additional","affiliation":[{"name":"Division of Palliative Medicine, Emory University Healthcare Midtown, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheria Y.","family":"Francis","sequence":"additional","affiliation":[{"name":"Collaborative Care Management, University of Pittsburgh Medical Center Presbyterian Shadyside, Pittsburgh, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Bango","sequence":"additional","affiliation":[{"name":"The Juniper Center, Chicago, Illinois, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Sager","sequence":"additional","affiliation":[{"name":"Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Janet","family":"Ho","sequence":"additional","affiliation":[{"name":"Division of Palliative Medicine, University of California San Francisco, San Francisco, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"National Institute on Drug Abuse. Overdose Death Rates. Bethesda MD; 2022. Available from: https:\/\/nida.nih.gov\/drug-topics\/trends-statistics\/overdose-death-rates [Last accessed: July 25 2022]."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1439"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2013.0153"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2021.0378"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.j.pain.0000460357.01998.f1"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049909119890556"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.05145"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108083"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061594"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-019-0443-4"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2015.0098"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2011.03.009"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2022.05.004"},{"key":"e_1_3_3_15_2","first-page":"859","article-title":"Buprenorphine\u2014An attractive opioid with underutilized potential in treatment of chronic pain","volume":"8","author":"Khanna IK","year":"2015","unstructured":"Khanna IK, , Pillarisetti S. Buprenorphine\u2014An attractive opioid with underutilized potential in treatment of chronic pain. J Pain Res, 2015; 8:859\u2013870; doi: 10.2147\/JPR.S85951","journal-title":"J Pain Res"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz356"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/NJH.0000000000000598"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S140320"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.suponc.2012.05.002"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0953-z"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.09.001"},{"key":"e_1_3_3_22_2","first-page":"8610538","article-title":"Differences between transdermal fentanyl and buprenorphine in the elderly hospice patients","volume":"2018","author":"Gol\u010di\u0107 M","year":"2018","unstructured":"Gol\u010di\u0107 M, , Dobrila-Dintinjana R, , Gol\u010di\u0107 G, et al. Differences between transdermal fentanyl and buprenorphine in the elderly hospice patients. Pain Res Treat, 2018; 2018:8610538; doi: 10.1155\/2018\/8610538","journal-title":"Pain Res Treat"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.21914"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-021-01032-7"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707598"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.04.009"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119872203"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13809"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570159043359477"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.38"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0284-1"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33961"},{"key":"e_1_3_3_33_2","unstructured":"US Department of Health and Human Services. Pain Management Best Practices Inter-Agency Task Force Report: Updates Gaps Inconsistencies and Recommendations. 2019. Available from: https:\/\/www.hhs.gov\/sites\/default\/files\/pain-mgmt-best-practices-draft-final-report-05062019.pdf [Last accessed: July 25 2022]."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000670"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S305146"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.2217\/pmt-2020-0013"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S120170"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2011.06.003"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2016.1128307"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S280572"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06251-w"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.7326\/M19-1488"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2020.02.001"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.759872"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.2217\/pmt-2018-0069"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2008.00204.x"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0b013e3282f5272e"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2007.00824.x"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14001"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241362"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S199245"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14105"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000646"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.aat.2015.06.001"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2012\/15\/ES231"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.7326\/L19-0725"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.39968"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2020.1822163"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000635"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108729"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000945"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-019-00143-6"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-019-00637-z"},{"issue":"1","key":"e_1_3_3_64_2","first-page":"1","article-title":"2020 Focused update [published correction appears in J Addict Med. 2020 May\/Jun;14(3):267]","volume":"14","author":"The ASAM national practice guideline for the treatment of opioid use disorder","year":"2020","unstructured":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 Focused update [published correction appears in J Addict Med. 2020 May\/Jun;14(3):267]. J Addict Med, 2020; 14(2S Suppl 1):1\u201391; doi: 10.1097\/adm.0000000000000683","journal-title":"J Addict Med"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011023431802"},{"key":"e_1_3_3_66_2","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"3","author":"Mattick RP","year":"2004","unstructured":"Mattick RP, , Kimber J, , Breen C, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev, 2004; 3:CD002207; doi: 10.1002\/14651858.CD002207.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2021.0650"},{"key":"e_1_3_3_69_2","unstructured":"Department of Health and Human Services . HHS Releases New Buprenorphine Practice Guidelines Expanding Access to Treatment for Opioid Use Disorder. 2021. Available from: https:\/\/www.hhs.gov\/about\/news\/2021\/04\/27\/hhs-releases-new-buprenorphine-practice-guidelines-expanding-access-to-treatment-for-opioid-use-disorder.html [Last accessed: July 25 2022]."},{"key":"e_1_3_3_70_2","unstructured":"American Society of Addiction Medicine. Buprenorphine Mini-Course: Building on Federal Prescribing Guidance. 2021. Available from: https:\/\/elearning.asam.org\/products\/buprenorphine-mini-course-building-on-federal-prescribing-guidance [Last accessed: July 25 2022]."},{"key":"e_1_3_3_71_2","unstructured":"American Society of Addiction Medicine. ASAM COVID-19 Task Force Recommendations: Caring for Patients During the COVID19 Pandemic. 2020. Available from: https:\/\/elearning.asam.org\/products\/caring-for-patients-during-the-covid-19-pandemic [Last accessed: July 25 2022]."},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1652"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael051"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-020-00795-3"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102722"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0196-4"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0866-8"},{"key":"e_1_3_3_79_2","unstructured":"Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville MD: Substance Abuse and Mental Health Services Administration (US); 2004."},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2022.0135"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1097\/CXA.0000000000000072"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2313"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.6749"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12869"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13135"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000864"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000745"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.74018"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000838"},{"key":"e_1_3_3_90_2","unstructured":"Centers for Disease Control. Dosing and Titration of Opioids: How Much How Long and How and When to Stop?: Applying CDC's Guideline for Prescribing Opioids. 2022. Available from: https:\/\/www.cdc.gov\/opioids\/providers\/training\/dosing.html [Last accessed July 25 2022]."},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1979.tb06325.x"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/56.8.855"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1982.tb02158.x"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1980.tb01584.x"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-021-00910-8"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2018-100205"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300251"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny019"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3265"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2016.01.032"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68700-X"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-2-200601170-00010"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.02.030"},{"key":"e_1_3_3_104_2","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18\u20135068 NSDUH Series H-53). Substance Abuse and Mental Health Services Administration: Rockville MD 2018."},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anclin.2018.04.002"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2006.01.013"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.04.043"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1080\/00952990902825413"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.03.018"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181be0804"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2011.10.021"},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X1304100212"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa020"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.10.007"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.03.044"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2021-103007"},{"key":"e_1_3_3_117_2","unstructured":"National Institute of Drug Abuse. Is the Use of Medications like Methadone and Buprenorphine Simply Replacing One Addiction with Another? 2020. Available from: https:\/\/nida.nih.gov\/publications\/principles-drug-addiction-treatment-research-based-guide-third-edition\/frequently-asked-questions\/use-medications-methadone-buprenorphine-simply-replacing [Last accessed: July 25 2022]."},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2021.S1.200236"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1300\/J132v08n01_18"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049909121999783"}],"container-title":["Journal of Palliative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jpm.2022.0399","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jpm.2022.0399","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jpm.2022.0399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:16:47Z","timestamp":1777655807000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jpm.2022.0399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1089\/jpm.2022.0399"],"URL":"https:\/\/doi.org\/10.1089\/jpm.2022.0399","relation":{},"ISSN":["1096-6218","1557-7740"],"issn-type":[{"value":"1096-6218","type":"print"},{"value":"1557-7740","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}